A man contacted us on behalf of his father, who was immunocompromised and receiving cancer treatments.
A man contacted us on behalf of his father, who was immunocompromised and receiving cancer treatments. He had applied to the Exceptional Access Program for funding for a drug necessary for managing the elder man’s conditions – which the EAP had approved for him before. He complained that EAP staff were now asking him to provide additional information. We made inquiries with EAP officials, confirmed why the additional information was required, and facilitated communication between them and the family. The man’s application was approved, and the funding was backdated to the time of his initial application.
